Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors

Figure 2

Receiver-operating curve for p-mTOR (a), SSTR2A (b), and IGF-1R (c) QSs and stage IIIB-IV at diagnosis.